Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013;18(10):1147.
doi: 10.1634/theoncologist.2013-0087.

Thiazolodinediones and cancer: duplicate publication bias?

Frank de Vries  1 , Maurice P Zeegers, Lotte M Knapen, Maria E Goossens
Affiliations
Comment

Thiazolodinediones and cancer: duplicate publication bias?

Frank de Vries et al. Oncologist. 2013.

Abstract

A meta-analysis of epidemiological studies reported no increased risk for cancer in users of thiazolidinediones; however, subanalyses showed a small 1.1- to 1.2-fold increased risk for bladder cancer with thiazolidinedione use. This analysis was probably distorted by “duplicate publication bias.”

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Comment in

  • In reply.
    Bosetti C, Rosato V, Buniato D, Zambon A, La Vecchia C, Corrao G. Bosetti C, et al. Oncologist. 2013;18(10):1148. doi: 10.1634/theoncologist.2013-0216. Oncologist. 2013. PMID: 24149712 Free PMC article.

Comment on

References

    1. Bosetti C, Rosato V, Buniato D, et al. Cancer risk for patients using thiazolidinediones for type 2 diabetes: A meta-analysis. The Oncologist. 2013;18:148–156. - PMC - PubMed
    1. Bodmer M, Meier C, Krahenbuhl S, et al. Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care. 2010;33:1304–1308. - PMC - PubMed
    1. Wei L, MacDonald TM, Mackenzie IS. Pioglitazone and bladder cancer: A propensity score matched cohort study. Br J Clin Pharmacol. 2013;75:254–259. - PMC - PubMed
    1. Azoulay L, Yin H, Filion KB, et al. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: Nested case-control study. BMJ. 2012;344:e3645. - PMC - PubMed
    1. Egger M, Davey-Smith G. Meta-analysis. Bias in location and selection of studies. BMJ. 1998;316:61–66. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources